PharmaMénta Aps: Financial statements 2014
CVR: 25615697
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
PharmaMénta Aps (CVR 25615697) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -2,025 and a net result of DKK 125,362 compared with DKK 135,521 the year before. Equity in the 2014 report amounted to DKK 4,259,192. The solvency ratio was 99.9%.
- Gross Profit
- DKK -2,025
- Profit/Loss
- DKK 125,362
- Equity
- DKK 4,259,192
- Total Assets
- DKK 4,262,443
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | -2 t. | 125 t. | 4.3 mio. | - |
| 2013 | - | -7 t. | 136 t. | 4.1 mio. | - |
| 2012 | - | -6 t. | 286 t. | 4 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
PharmaMénta Aps has published its annual report for 2013. Gross profit came to DKK -6,555, and the net result was DKK 135,521.
About PharmaMénta Aps
PharmaMénta Aps is a Danish company of the type Anpartsselskab based in Esbjerg V, founded in 2000. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jimmi Javed Christensen Malik. The board consists of Lasse Hvingelby Kikkenborg (chair), Jimmi Javed Christensen Malik and Torben Hvingelby Pedersen. The company is owned by Torben Hvingelby Pedersen, LHK Holding Esbjerg ApS and JMINT Holding ApS. The company has 3 employees (2008). In 2025, the company reported a gross profit of DKK 5,249,012 and a net result of DKK 2,364,968 compared with DKK 2,121,363 the year before. Equity in the 2025 report amounted to DKK 5,130,022.